期刊文献+

补体C3f去精氨酸片段对系统性硬化症小鼠皮肤纤维化模型构建及转化生长因子β1表达的影响 被引量:1

Effection of DRC3f on the dermatofibrosis and TGF-β1 expression of systemic sclerosis mice
下载PDF
导出
摘要 目的探讨补体C3f去精氨酸片段(DRC3f)对于系统性硬化症(SSc)小鼠皮肤纤维化模型构建和转化生长因子(TGF)-β1表达的影响。方法采用DRC3f联合博来霉素皮下注射的方法构建SSc小鼠模型,并用纤维染色和免疫组化方法比较联合与不联合DRC3f对SSc小鼠皮肤纤维化、皮肤增厚程度和TGF-β1表达的影响。结果联合DRC3f和博来霉素注射组与单用博来霉素和博来霉素联合无关多肽组比较,皮肤纤维化程度更加明显,TGF-β1的表达也明显增多(P<0.05)。结论 DRC3f能够促进SSc模型小鼠皮肤纤维化和炎症因子TGF-β1的表达。 Objective To investigate the effection of DRC3 f in the dermatofibrosis and TGF-β1 expression of systemic sclerosis mice. Methods The systemic sclerosis mice model was made by hypodermic of DRC3 f combined with Bleomycin. The expression of TGF-β1and the level of dermatofibrosis were detected by immunohistochemistry and fibro-stain respectively. Results The level of dermatofibrosis and the expression of TGF-β1 were much higher in the group which was injected of DRC3 f combined with Bleomycin. Conclusions The DRC3 f might probably promote the dermatofibrosis and the expression of TGF-β1 of systemic sclerosis mice.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2016年第13期3092-3094,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金项目(81260458) 湖北省自然科学基金项目(2012FFA061)
关键词 补体C3f去精氨酸片段 系统性硬化症 皮肤纤维化 转化生长因子-β1 DRC3f Systemic sclerosis mice Dermatofibrosis TGF-β1
  • 相关文献

参考文献12

  • 1Pattanaik D,Brown M,Postlethwaite AE.Vascular involvement in systemic sclerosis(scleroderma)[J].J Inflam Res,2011;4(1):105-25.
  • 2Jacobsen S,Halberg P,Ullman S.Mortality and causes of death of 344Danish patients with systemic sclerosis(scleroderma)[J].Br J Rheumatol,1998;37(7):750-5.
  • 3Steen VD,Medsger TA.Changes in causes of death in systemic sclerosis,1972-2002[J].Ann Rheum Dis,2007;66(7):940-4.
  • 4Belch JJ,Mc Swiggan S,Lau C.Macrovascular disease in systemic sclerosis:the tip of an iceberg[J]?Rheumatology(Oxford),2008;47(10):v16-7.
  • 5Kahaleh MB,LeRoy EC.Autoimmunity and vascular involvement in systemic sclerosis(SSc)[J].Autoimmunity,1999;31(3):195-214.
  • 6Arnson Y,Amital H,Guiducci S,et al.The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies[J].Ann N Y Acad Sci,2009;1173(1):627-32.
  • 7Hebbar M,Lassalle P,Delneste Y,et al.Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren's syndrome[J].Ann Rheum Dis,1997;56(4):230-4.
  • 8Wusirika R,Ferri C,Marin M,et al.The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis.A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma[J].Am J Clin Pathol,2003;120(4):596-606.
  • 9Benbassat C,Schlesinger M,Luderschmidt C,et al.The complement system and systemic sclerosis[J].Immunol Res,1993;12(3):312-6.
  • 10Xiang Y,Kurokawa MS,Kanke M,et al.Peptidomics:identification of pathogenic and marker peptides[J].Methods Mol Biol,2010;615(15):259-71.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部